/Companies

US Worldmeds

1 known investors

Find your way into US Worldmeds

Sign up to see every warm intro you have to US Worldmeds

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the US Worldmeds team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

US WorldMeds is a privately held specialty pharmaceutical company that licenses, develops, and markets medicines for patients with rare and challenging conditions. Its products include an FDA-approved engineered T-cell therapy for solid tumors.

Founders & leadership

BJ
Breck Jones
KG
Kristen Gullo
TC
Thomas Clinch

Investors · 1

Frequently asked questions

What does US Worldmeds do?
US WorldMeds is a privately held specialty pharmaceutical company that licenses, develops, and markets medicines for patients with rare and challenging conditions. Its products include an FDA-approved engineered T-cell therapy for solid tumors.
Who are US Worldmeds's investors?
US Worldmeds's investors include Keyhorse Capital.